➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Dow
Merck
Harvard Business School

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

MEDROXYPROGESTERONE ACETATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for medroxyprogesterone acetate and what is the scope of patent protection?

Medroxyprogesterone acetate is the generic ingredient in seven branded drugs marketed by Pharmacia And Upjohn, Amphastar Pharms Inc, Cipla, Mylan Labs Ltd, Sandoz Inc, Sun Pharm, Teva Pharms Usa, Amarin Pharms, Solvay, Esi , Barr, Duramed Pharms Barr, and Upsher Smith Labs, and is included in twenty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Medroxyprogesterone acetate has forty-three patent family members in twenty-nine countries.

There are twenty drug master file entries for medroxyprogesterone acetate. Nineteen suppliers are listed for this compound.

Drug Prices for MEDROXYPROGESTERONE ACETATE

See drug prices for MEDROXYPROGESTERONE ACETATE

Recent Clinical Trials for MEDROXYPROGESTERONE ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Intercommunal CreteilPhase 3
Ohio State UniversityPhase 4
Nationwide Children's HospitalPhase 4

See all MEDROXYPROGESTERONE ACETATE clinical trials

Pharmacology for MEDROXYPROGESTERONE ACETATE
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for MEDROXYPROGESTERONE ACETATE

US Patents and Regulatory Information for MEDROXYPROGESTERONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Esi CYCRIN medroxyprogesterone acetate TABLET;ORAL 081239-001 Oct 30, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040311-002 Dec 1, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Barr MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159-002 Aug 9, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Amarin Pharms AMEN medroxyprogesterone acetate TABLET;ORAL 083242-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 088484-001 Jul 26, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MEDROXYPROGESTERONE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-SUBQ PROVERA 104 medroxyprogesterone acetate INJECTABLE;SUBCUTANEOUS 021583-001 Dec 17, 2004   Start Trial   Start Trial
Pharmacia And Upjohn DEPO-PROVERA medroxyprogesterone acetate INJECTABLE;INJECTION 012541-003 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for MEDROXYPROGESTERONE ACETATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0113964 97C0037 Belgium   Start Trial PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Colorcon
Boehringer Ingelheim
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.